From February 26, 2024 to March 26, 2024, the company has repurchased 210,800 shares, representing 6.33% for ¥189.93 million. With this, the company has completed the repurchase of 210,800 shares, representing 6.33% for ¥189.93 million under the buyback announced on February 26, 2024.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1,100 JPY | +2.23% | +1.85% | +9.89% |
1st Jan change | Capi. | |
---|---|---|
+9.89% | 23.96M | |
-10.75% | 8.88B | |
+39.05% | 1.43B | |
+8.27% | 438M | |
-2.22% | 268M | |
+10.56% | 226M | |
-8.26% | 86.33M | |
-46.43% | 82.6M | |
+23.75% | 62.75M |
- Stock Market
- Equities
- 9776 Stock
- News Sapporo Clinical Laboratory Inc.
- Tranche Update on Sapporo Clinical Laboratory Inc.'s Equity Buyback Plan announced on February 26, 2024.